Quassinoids: From Traditional Drugs to New Cancer Therapeutics
Keywords: Ailanthus altissima; Anticancer therapeutics; C-ring; Ethiopia; Eurycoma longifolia; Natural products; Phosphorylation; RNA transcripts; Simaroubaceae; Simaroubaceae family; alkyl groups; anti-cancer activity; anti-inflammatory activities; anti-ulcer; anti-viral; antineoplastic proper-ties; apoptosis in leukemia cells; biogenesis; breast cancer; breast carcinoma; bruceantin; brusatol; carcinogenesis; cell proliferation; chemopreventive agents; condensation; death; endothelial growth factor; epoxy-methano bridge; ester; ester side chain; ethanolic extract of Brucea; eurycomalide; extracellular signal-regulated kinase; fibroblasts; glutathione; glycosylation; human pancreatic adenocarcinoma; hydroxyl substituents; hypotension; hypoxia; isolated; leukemic cell; leukemic cells; lipophilic ester side chain; lipophilicity; lymphoma; malaria; medicinal agents; myeloma cell lines; nucleic acid; oncogene; oxygen-methylene bridge; peptide bond formation; peptidyl-transferase site; polarization; post-translational levels; potency; proteins; quassinoids; tigloyloxy group; tigloyloxychaparrinone; translocation of NF-B; tumor; vomiting
Document Type: Research Article
Publication date: 2011-01-01
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.